Dan Brennan
Stock Analyst at TD Securities
(3.80)
# 581
Out of 4,843 analysts
107
Total ratings
50%
Success rate
8.64%
Average return
Main Sectors:
Stocks Rated by Dan Brennan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GH Guardant Health | Maintains: Buy | $56 → $60 | $40.62 | +47.71% | 2 | May 1, 2025 | |
| WGS GeneDx Holdings | Maintains: Buy | $135 → $110 | $71.22 | +54.45% | 4 | May 1, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Neutral | $8 → $2.5 | $2.25 | +11.11% | 4 | Mar 21, 2025 | |
| TEM Tempus AI | Reinstates: Buy | $74 | $55.18 | +34.11% | 2 | Feb 5, 2025 | |
| EXAS Exact Sciences | Maintains: Buy | $82 → $86 | $56.28 | +52.81% | 6 | Nov 26, 2024 | |
| NTRA Natera | Maintains: Buy | $155 → $175 | $157.73 | +10.95% | 4 | Nov 13, 2024 | |
| CRL Charles River Laboratories International | Maintains: Buy | $240 → $250 | $135.63 | +84.33% | 5 | Nov 7, 2024 | |
| BRKR Bruker | Maintains: Hold | $72 → $70 | $36.70 | +90.74% | 1 | Nov 6, 2024 | |
| ILMN Illumina | Maintains: Buy | $166 → $177 | $82.24 | +115.22% | 12 | Nov 5, 2024 | |
| RVTY Revvity | Maintains: Buy | $141 → $144 | $90.42 | +59.26% | 3 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $363 → $410 | $349.24 | +17.40% | 3 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $310 → $315 | $189.90 | +65.88% | 5 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $153 → $160 | $111.92 | +42.96% | 12 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $28 → $30 | $4.19 | +615.99% | 1 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $31 | $12.91 | +140.12% | 3 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $648 → $658 | $402.82 | +63.35% | 12 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $51 | $43.96 | +16.01% | 2 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $2.8 | $0.30 | +827.15% | 1 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $20 | $7.27 | +175.10% | 6 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $57 → $32 | $9.53 | +235.78% | 4 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $545 → $546 | $316.67 | +72.42% | 4 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $7 | $2.11 | +232.54% | 1 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $13 → $15 | $0.96 | +1,456.50% | 1 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $207 → $232 | $130.28 | +78.08% | 6 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $770 → $880 | $1,155.52 | -23.84% | 3 | Oct 7, 2020 |
Guardant Health
May 1, 2025
Maintains: Buy
Price Target: $56 → $60
Current: $40.62
Upside: +47.71%
GeneDx Holdings
May 1, 2025
Maintains: Buy
Price Target: $135 → $110
Current: $71.22
Upside: +54.45%
Maravai LifeSciences Holdings
Mar 21, 2025
Maintains: Neutral
Price Target: $8 → $2.5
Current: $2.25
Upside: +11.11%
Tempus AI
Feb 5, 2025
Reinstates: Buy
Price Target: $74
Current: $55.18
Upside: +34.11%
Exact Sciences
Nov 26, 2024
Maintains: Buy
Price Target: $82 → $86
Current: $56.28
Upside: +52.81%
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $155 → $175
Current: $157.73
Upside: +10.95%
Charles River Laboratories International
Nov 7, 2024
Maintains: Buy
Price Target: $240 → $250
Current: $135.63
Upside: +84.33%
Bruker
Nov 6, 2024
Maintains: Hold
Price Target: $72 → $70
Current: $36.70
Upside: +90.74%
Illumina
Nov 5, 2024
Maintains: Buy
Price Target: $166 → $177
Current: $82.24
Upside: +115.22%
Revvity
Nov 5, 2024
Maintains: Buy
Price Target: $141 → $144
Current: $90.42
Upside: +59.26%
Nov 4, 2024
Maintains: Hold
Price Target: $363 → $410
Current: $349.24
Upside: +17.40%
Oct 23, 2024
Maintains: Buy
Price Target: $310 → $315
Current: $189.90
Upside: +65.88%
Aug 22, 2024
Maintains: Buy
Price Target: $153 → $160
Current: $111.92
Upside: +42.96%
Aug 7, 2024
Maintains: Hold
Price Target: $28 → $30
Current: $4.19
Upside: +615.99%
Jul 29, 2024
Maintains: Buy
Price Target: $28 → $31
Current: $12.91
Upside: +140.12%
Jul 25, 2024
Maintains: Buy
Price Target: $648 → $658
Current: $402.82
Upside: +63.35%
Jul 23, 2024
Maintains: Buy
Price Target: $48 → $51
Current: $43.96
Upside: +16.01%
May 13, 2024
Initiates: Buy
Price Target: $2.8
Current: $0.30
Upside: +827.15%
May 1, 2024
Maintains: Buy
Price Target: $21 → $20
Current: $7.27
Upside: +175.10%
May 1, 2024
Downgrades: Hold
Price Target: $57 → $32
Current: $9.53
Upside: +235.78%
Dec 8, 2023
Maintains: Outperform
Price Target: $545 → $546
Current: $316.67
Upside: +72.42%
May 31, 2023
Initiates: Outperform
Price Target: $7
Current: $2.11
Upside: +232.54%
Mar 31, 2023
Upgrades: Outperform
Price Target: $13 → $15
Current: $0.96
Upside: +1,456.50%
Mar 1, 2021
Upgrades: Buy
Price Target: $207 → $232
Current: $130.28
Upside: +78.08%
Oct 7, 2020
Downgrades: Sell
Price Target: $770 → $880
Current: $1,155.52
Upside: -23.84%